Market Share of Global Psoriasis Drugs Industry
The psoriasis drugs market is moderately competitive and consists of several key players. Concerning the market share, few of the key players currently dominate the market. Companies are focusing on business expansion in developing regions or emerging markets, such as India, China, and South Korea, by adopting strategies, including alliances and acquisitions, to develop novel products. Some of the major players operating in the market include AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen Idec, Boehringer Ingelheim, Celgene Corporation, Dr. Reddy`s Laboratories, Eli Lilly and Company, Forward Pharma, Johnson and Johnson (Janssen Biotech Inc.), Leo Pharma AS, Merck and Co. Inc., Novartis AG and Pfizer Inc. among others.
Psoriasis Drugs Market Leaders
-
Eli Lilly and Company
-
Pfizer Inc.
-
Johnson and Johnson (Janssen Global Services, LLC)
-
Novartis AG
-
Amgen Inc.
*Disclaimer: Major Players sorted in no particular order
